Synthesis of novel 3-[(dialkyl/aryl amino) methyl]-2-substituted-4(3H)-Quinazolinones and evaluation of their Anti-inflammatory activity

 

Ganesh Akula1*, Rangu Nirmala2, CH. Shanthipriya2, S. Rohini Reddy2, Dr. A. Jaswanth2

1Department of Pharmaceutical Chemistry, Surabhi Dayakar Rao College of Pharmacy, Rimmanaguda (V), Gajwel (M), Siddipet (D), Telangana-502312

2Surabhi Dayakar Rao College of Pharmacy, Rimmanaguda (V), Gajwel (M), Siddipet (D), Telangana-502312

*Corresponding Author E-mail: akulaganesh@gmail.com

 

ABSTRACT:

Literature survey reveals that in recent years several Quinazolinone derivatives have been synthesized and reported to possess varied biological and pharmacological properties. They are found to be useful as antibacterial, analgesic, anti-inflammatory, antifungal, anticonvulsant and anticancer agents. A new series of 3-[(di alkyl amino) methyl]-2-substituted-4(3H)-Quinazolinones were synthesized by the reaction of a mixture of 2-substituted-4(3H)-Quinazolinone, formaldehyde and dialkyl or diaryl amine by mannich reaction. The chemical structures of the synthesized compounds were confirmed by IR, mass spectral and C, H, N analysis techniques. The synthesized compounds were screened for anti-inflammatory activity by the carrageenan induced rat hind paw edema method. The synthesized compounds were significantly showed their anti-inflammatory activity that of standard.

 

KEY WORDS: Quinazolinone, Isomer, Analgesic, Anti-inflammatory, Carrageenan

 

 


1. INTRODUCTION:

Quinazoline1,2 is a bicyclic compound prepared by fusing  of six-membered simple aromatic rings consisting of pyrimidine system with benzene, viewing array of  applications. The many derivatives of quinazoline system known so far, keto-quinazolines also called as Quinazolinone3, are the most important compounds. Literature survey reveals that in recent years several Quinazolinone derivatives4,5,6 have been synthesized and reported to possess varied biological and pharmacological properties.  They are found to be useful as antibacterial7,8, analgesic9, anti-inflammatory10, antifungal11-14, anticonvulsant15 and anticancer agents16,17.

 

In the present investigation, synthesis of Quinazolinone derivatives were carried out according to scheme-1 and these compounds were evaluated for their pharmacological activities especially antimicrobial activity. These compounds showed pharmacological activity in comparison with the standard compounds.

 

2. MATERIALS AND METHODS:

All chemicals are of analytical grade and are brought from Sd. fine Chem. Ltd. The melting points were recorded on technico apparatus and were uncorrected.

 


 

Scheme-1

 

Compounds: a1– c2

Compound a: R= C6H5,                  a1: R1= R2= CH3, a2: R1= R2= C6H5

Compound b: R= CH3,                      b1: R1= R2= CH3, b2: R1= R2= C6H5

Compound c: R= H,                       c1: R1= R2= CH3, c2: R1= R2= C6H5

 


Step-I: Synthesis of 2-substituted-4(3H)-Quinazolinone (compound a-c): Ortho amino benzoic acid (0.1mole) was dissolved in 100ml of methanolic potassium hydroxide. Then gradually added alkyl or aryl amide (0.1 moles), the contents were refluxed for 3-4 hours and were cooled at room temperature. The reaction mixture was filtered and washed with methanol and dry the product. The dried crude product was recrystallized from methanol to get the compound.

 

Step-II: Synthesis of 3-[(dialkyl/aryl amino) methyl]-2-substituted-4(3H)-Quinazolinones (compound a1-c1 and a2-c2):  2-substituted-4(3H)-Quinazolinone (0.01 mole) was taken in 5 ml of 95% Ethanol and slurry was formed. To this 37% formaldehyde (0.02mole) and dialkyl or diaryl amine (0.01 moles) gradually added then a clear solution was obtained. To this solution 95% ethyl alcohol was added and it was concentrated by evaporation on a hot plate until a semisolid was formed and re-crystallized with ethanol.

Anti-inflammatory Activity18: The anti-inflammatory activity of the test compound was determined by rabbit hind paw edema method. A 1% W/V solution of carrageenan (0.1ml) as the phlogistic agent was used to induce inflammation. By measuring the change in paw volume of mercury displaced by the inflamed paw in plethysmograph, the extent of reduction was determined for each compound which in turn reflects directly on the anti-inflammatory activity of compounds. Control drug at a dose of 100mg/kg was employed as the standard drug. The control group was maintained with normal saline. Albino rats were divided into six groups of four animals each. Initial paw volume (both left and right) of each rat was recorded using plethysmograph. Test compounds were prepared in a 0.3% suspension of Carboxy Methyl Cellulose and given by oral route at a dose of 100mg/kg subcutaneously. After 30min of administration of test and standard compounds, 0.1ml of 1% carrageenan in 0.9% saline was injected subcutaneously in the sub plantar region of left hind paw of each animal. After the lapse of 3 hours following the injection of carrageenan, the change in the paw volume of each animal was measured by using plethysmograph. Control groups received 0.3ml of normal saline sub cutaneous. Paw volumes of control group were compared with the standard and test. The paw volume of albino rats was measured and shown in table-1.

 

3. RESULTS AND DISCUSSION:

Various novel Derivatives of 3-[(dialkyl/aryl amino) methyl]-2-substituted-4(3H)-Quinazolinone were synthesized from Quinazolinone by Mannich reaction with 37% Formaldehyde, dimethyl amine or diphenyl amine and Ethanol.  For the synthesis of Quinazolinone, Anthranilic acid was taken as a starting material by condensing with the amide and Methanolic Potassium hydroxide.

 

Anti-inflammatory Activity: Table-1 showing the data on anti-inflammatory activity of the compounds could reveal that all the six compounds could exhibit a moderate to potent activity. Compounds a2, b2, and c2 showed potent anti-inflammatory activity and its activity were found to be comparable to that of the standard drug Indomethacin.

 


 

TABLE-1:Results of Anti-inflammatory activity in Albino Rats

S.no

Compounds

No. of rats

Mean initial paw volume

Mean final paw volume

Mean change in paw volume

1

Standard

4

0.53

0.48

0.06

2

Compound a1

4

0.52

0.50

0.02

3

Compound a2

4

0.56

0.50

0.06

4

Compound b1

4

0.54

0.52

0.02

5

Compound b2

4

0.53

0.47

0.06

6

Compound c1

4

0.57

0.54

0.03

7

Compound c2

4

0.50

0.46

0.04

*Oral Dose: 100mg/kg

 


4. CONCLUSION:

In present work we have synthesized some of the derivatives of Quinazolinone by different substitutions like dimethyl and diphenyl. It is interesting that new three (a2, b2, c2) Quinazolinone derivatives possess significant anti-inflammatory activity comparable with the standard employed (Indomethacin). It is desirable to determine their toxicity to decide on whether to go for further screening or not.

 

5. ACKNOWLEDGEMENT:

I am very much thank full to the management of Surabhi Dayakar Rao College of Pharmacy for providing necessary facilities. I am also grateful to my colleagues and my friends for their kind help from time to time at each and every step of this work.

 

6. REFERENCES:

1.     Raj K. Bansal, Hetero Cyclic Chemistry, 4th edition, new age international publishers, New Delhi, 2005.

2.     Chakravarthi and Chakravarthi, J. Indust. Chem. India, 1952; 24: 96-99.

3.     Chatterjee and Majumdar, J.Am.Chem.Soc.1953;75: 4365-4369.

4.     I.Philipova et al, Convenient synthesis of some 2-substituted- 4(3H)-Quinazolinone derivatives, J. Hetero cyclic chem., 2006; 43: 1057-1062.

5.     Mazaahir Kidwai et al, synthesis of Quinazolinone analogues using sodium perborate catalyst, Indian journal of chemistry, 2007; 47(B), 1876-1881.

6.     Ahmad  Momeni Tikdari et al, Synthesis of new 4(3H)-Quinazolinone derivatives using 5(4H)-Quinazolinone derivatives using 5(4H)-Oxazolones, Molecules,  2006; 11: 377-382.

7.     Hassanzadeh et al, antibacterial, antifungal, cytotoxic evaluation of some new Quinazolinone derivatives, Research in Pharmaceutical Sciences, 2012; 7(2):87-94.

8.     Deepti Kohli et al, Synthesis and antibacterial activity of Quinazolinone derivatives, International Journal of Pharmacy and Pharmaceutical Sciences, 2009; 1(1), 45-49.

9.     CH. Rajveer et al, Synthesis of some 6- Bromo Quinazolinone derivatives for their pharmacological activities, Indian Journal of Pharma and Bio sciences, 2010; 1(3): 1-10

10.   B.Kiruthiga et al, Synthesis of some new 2- substituted  Quinazolin-4-one derivatives and their biological activities, International Journal of Pharm Tech Research, 2009; 1(4):1503-1506.

11.   Sarika Mehta et al, Synthesis and characterization of some quinazoline derivatives as potential antimicrobial agents under micro wave irradiation, bull. Korean Chem. Soc. 2007, 28(12): 4628-4634.

12.   A. Aly et al, Synthesis and surface active properties of condensed and non-condensed quinazoline derivatives for industrial application, Indian journal of chemistry, 2006; l 45(B):1020-1027.

13.   Kishor R. Desai et al, Niementowski reaction: micro wave induced and conventional synthesis of Quinazolinones and 3-methyl-1H-5-pyrazolones and their antimicrobial activity, ARKIVOC, 2005 (xiii):98-108.

14.   M.K. Shivananda et al, antifungal activity studies of some Quinazolinone derivatives, Journal of Chemical and Pharmaceutical Research, 2011, 3(3): 83-86.

15.   Ponnilavarasan Ilangovan et al, Design and synthesis of novel Quinazolinone derivatives as broad spectrum anticonvulsant and antimicrobial agent, Journal of Pharmacy Research, 2010, 3(4), 703-706.

16.   G.A. Khodarhami et al, Synthesis and cytotoxic evaluation of some new 4(3H)-Quinazolinones and on HeLa cell line, Research in Pharmaceutical Sciences, 2012; 7(2): 119-125.

17.   K. Manasa et al, Synthesis, antioxidant and anticancer activity of quinazoline derivatives, Current Pharma Research, 2011; 1(2):101- 105.

18.   Omar Abd El-Fattah M. Fathalla et al, Synthesis of some new Quinazoli-4-one derivatives and evaluation of their antimicrobial and anti-inflammatory effects, Acta Poloniae Pharmaceutica- Drug Research, 2008; 65(1): 11-20.

 

 

 

 

 

 

Received on 13.03.2017       Accepted on 28.05.2017     

© Asian Pharma Press All Right Reserved

Asian J. Pharm. Res. 2017; 7(2): 60-62.

DOI:  10.5958/2231-5691.2017.00010.7